Halozyme Therapeutics, Inc.
HALO
$57.29
-$1.50-2.55%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 77.40% | 37.87% | 51.90% | 68.16% | -7.39% |
Total Receivables | 31.70% | 31.48% | -12.86% | 0.52% | 1.36% |
Inventory | 11.17% | 1.93% | 20.32% | 56.75% | 27.44% |
Prepaid Expenses | -19.88% | -12.05% | 118.42% | 23.46% | 7.97% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 45.41% | 28.21% | 29.00% | 42.04% | 1.00% |
|
|||||
Total Current Assets | 45.41% | 28.21% | 29.00% | 42.04% | 1.00% |
Net Property, Plant & Equipment | 0.12% | -0.24% | 0.59% | 0.14% | -0.83% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.14% | 1.90% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.14% | 1.90% |
Total Other Intangibles | -15.02% | -14.48% | -14.41% | -13.94% | -13.50% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 280.38% | 154.25% | 23.97% | -70.80% | -68.83% |
Total Assets | 19.05% | 11.91% | 8.78% | 8.36% | -5.88% |
|
|||||
Total Accounts Payable | -13.26% | -35.82% | 52.47% | 53.25% | -33.22% |
Total Accrued Expenses | 20.98% | 162.17% | -16.50% | 35.84% | 3.09% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -94.23% | -87.48% | -- |
Total Finance Division Other Current Liabilities | -- | -- | 47.86% | 66.27% | -- |
Total Other Current Liabilities | -- | -- | 47.86% | 66.27% | -- |
Total Current Liabilities | 23.65% | -5.53% | 14.58% | 43.21% | -13.99% |
|
|||||
Total Current Liabilities | 23.65% | -5.53% | 14.58% | 43.21% | -13.99% |
Long-Term Debt | 0.44% | 0.44% | 0.44% | 0.43% | 0.43% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -26.54% | 8.21% | -1.19% | 5.51% | -1.50% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 463.19% | 858.85% | -15.45% | -- | -64.30% |
Total Liabilities | 3.04% | 1.33% | 1.24% | 1.84% | -1.33% |
|
|||||
Common Stock & APIC | -95.15% | 141.59% | 153.07% | 8,931.06% | -90.78% |
Retained Earnings | 297.43% | 78.88% | 85.56% | 154.78% | -36.77% |
Treasury Stock & Other | 141.27% | -665.53% | -28.05% | -6,291.67% | -906.29% |
Total Common Equity | 334.11% | 81.68% | 91.63% | 170.02% | -50.64% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 334.11% | 81.68% | 91.63% | 170.02% | -50.64% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 334.11% | 81.68% | 91.63% | 170.02% | -50.64% |
|